Logo for Athenex Inc

Athenex Investor Relations Material

Latest events

Logo for Athenex Inc

Q3 2022

Logo for Athenex

Q4 2022

20 Mar, 2023
Logo for Athenex

Corporate Presentation

2 Jan, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Athenex Inc

Access all reports
Athenix Inc is a biopharmaceutical company engaged in the development and commercialization of drugs for the treatment of cancer. The company's Orascovery product candidates include Oral paclitaxel and encequidar, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in cutaneous angiosarcoma, advanced gastric cancer, and advanced solid malignancies. It also offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis.